Additional Benefit of Switching to Donidalorsen for Patients with Hereditary Angioedema Having Breakthrough Attacks: Findings from the OASISplus Study

Marc A. Riedl; Aaron S. Yarlas; Jane Lazar Tucker; Evy van Roij; Tamra Keeney; Alexandra J. Feld; Lauren Henning; Martha S. Bayliss; Laura Bordone; Sabrina Treadwell; Kenneth Newman; Aleena Banerji

doi:10.1016/j.jaci.2025.12.169

Additional Benefit of Switching to Donidalorsen for Patients with Hereditary Angioedema Having Breakthrough Attacks: Findings from the OASISplus Study

Journal of Allergy and Clinical Immunology 2026 Open access

Read full text

Authors: Marc A. Riedl, Aaron S. Yarlas, Jane Lazar Tucker, Evy van Roij, Tamra Keeney, Alexandra J. Feld, Lauren Henning, Martha S. Bayliss, Laura Bordone, Sabrina Treadwell, Kenneth Newman, Aleena Banerji

DOI: 10.1016/j.jaci.2025.12.169

Cited by: 0

Fields of Study & Subjects

Coagulation Bradykinin Polyphosphates and Angioedema Hemophilia Treatment and Research Mast cells and histamine

Publication details

Journal / source: Journal of Allergy and Clinical Immunology
Volume: 157
Issue: 2
Pages: AB56–AB56
Publication date: 1 February 2026
Language: EN